Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
What is Tucatinib?Tucatinib is an oral targeted therapy drug that must be used in combination with Herceptin® (trastuzumab) and Xeloda® (capecitabine). It is indicated for adult pa···【more】
Article source：Captain MedicineRelease date：2026-05-25Recommended：159
Brigatinib: Serious and Common Side EffectsBrigatinib may cause a variety of side effects, not everyone experiences them. If the following serious reactions occur, tell your doctor···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：178
Standard Dosage and Initial Treatment Regimen of BrigatinibBrigatinib must be taken exactly as directed by your doctor or pharmacist. The recommended dosage is given in two phases:···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：135
Indications and Mechanism of Action of BrigatinibBrigatinib is used to treat adult patients with advanced non-small cell lung cancer, especially those whose tumors have a genetic d···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：132
Health conditions you must tell your doctor about before using brigatinibBefore starting treatment with Alunbrig (brigatinib) and during treatment, you must contact your doctor imm···【more】
Article source：Captain MedicineRelease date：2026-05-22Recommended：134
Serious Side Effects Warnings for Brigatinib (Alunbrig)Brigatinib (Alunbrig) may cause serious side effects, and patients need to be highly vigilant. First, lung problems: Brigatin···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：138
Brigatinib for Second-Line Treatment After Progression on CrizotinibAlthough targeted therapy has brought hope to patients with ALK-positive NSCLC, unfortunately, even after treatm···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：143
How effective is the treatment with Brigatinib (Alunbrig)?A pivotal clinical study of brigatinib enrolled a total of 275 patients with ALK-positive NSCLC that had spread to other p···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：122
Mechanism of Action of Brigatinib (Alunbrig)Brigatinib (Alunbrig) is an oral prescription targeted therapy drug belonging to the class of tyrosine kinase inhibitors (TKIs). It work···【more】
Article source：Captain MedicineRelease date：2026-05-21Recommended：112
Recommended Dosage and Administration of CrizotinibThe recommended dosage for adults with non-small cell lung cancer is 250 mg (one capsule) each time, taken twice daily (morning a···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：121
Drug Interaction Risks of Crizotinib with Other MedicationsCrizotinib has many drug interactions that may increase side effects or reduce efficacy. Medications to avoid include cer···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：134
Absolute Contraindications and Allergic Reactions to CrizotinibCrizotinib is contraindicated in the following situations: hypersensitivity to crizotinib or any other ingredients in···【more】
Article source：Captain MedicineRelease date：2026-05-20Recommended：118
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
